.png)
Agenzia Italiana del Farmaco
home
COVID-19
Learn more
Highlights
-
28 Jun 2022
Transparency Lists
AIFA updates the Transparency Lists
AIFA has published the updated Transparency Lists of generic medicines together with the related reference prices, updated at 15 June 2022.
-
24 Jun 2022
Monitoring Registers
Monitoring of antivirals for COVID-19: eleventh report published
The Italian Medicines Agency (AIFA) has published the results of the monitoring of antivirals currently available for treating COVID-19.
-
23 Jun 2022
Monitoring Registers
Monitoring of monoclonal antibodies for COVID-19: weekly report published
AIFA publishes the results of the monitoring related to monoclonal antibodies for the treatment of COVID-19 currently available.
-
20 Jun 2022
Safety of medicinal products
New National Pharmacovigilance Network (RNF) launched
Forms for reporting adverse reactions have changed and it will be possible to report online directly from the AIFA portal
News
30 Jun 2022
Monitoring Registers
Hepatitis C: update of 27 June 2021 concerning enrolled patients
24 Jun 2022
Safety of medicinal products
EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17
24 Jun 2022
Safety of medicinal products
EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU
20 Jun 2022
Safety of medicinal products
Start of rolling review for adapted Spikevax COVID-19 vaccine
16 Jun 2022
Safety of medicinal products
Direct communication with healthcare professionals on Dexmedetomidine
15 Jun 2022
Safety of medicinal products
Start of rolling review for adapted Comirnaty COVID-19 vaccine
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
